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We report the case of a 14-year-old girl with a wide non-compressive pineal cyst, associated with the inability to control her sleep-wake schedule. Actigraphic 
monitoring showed a 24-hour free-running disorder (tau 26.96 hours). A 24-hour serum melatonin curve assay, with concomitant video-polysomnographic 
and body-core temperature monitoring, was performed. Melatonin curve showed a blunted nocturnal peak, lower total quantity of melatonin, and prolonged 
melatonin secretion in the morning, with normal temperature profile and sleep parameters. Treatment with melatonin up to 14 mg at bedtime was initiated 
with complete realignment of the sleep-wake rhythm (tau 23.93 hours). The role of the pineal cyst in the aforementioned alteration of melatonin secretion and 
free-running disorder remains controversial, but our case supports the utility of monitoring sleep/wake, temperature, and melatonin rhythms in the diagnostic 
work-up of pineal cysts associated with free-running disorder.
Keywords: actigraphy, body-core temperature, free-running disorder, melatonin, pineal cyst
Citation: Ferri L, Filardi M, Moresco M, Pizza F, Vandi S, Antelmi E, Toni F, Zucchelli M, Pierangeli G, Plazzi G. Non-24-hour sleep-wake rhythm disorder and 
melatonin secretion impairment in a patient with pineal cyst. J Clin Sleep Med. 2017;13(11):1355–1357.
INTRODUCTION
Non-24-hour sleep-wake rhythm disorder, also known as free-
running disorder (FRD), is a circadian rhythm sleep-wake dis-
order (CRSWD) characterized by the inability to maintain an 
entrained circadian sleep-wake rhythm with dissociation be-
tween the endogenous circadian phase and the external clock 
time, leading to insomnia and excessive daytime sleepiness.1 
Lack of concentration and social dysfunction are also part of 
the disorder.1,2
FRD affects a significant proportion of blind subjects and is 
rarely reported in sighted persons, with a higher prevalence in 
young males with comorbid psychiatric disorders.1 In sighted 
subjects, most cases remains idiopathic, but few studies re-
ported CRSWD in patients with hypothalamic lesions, namely 
tumors, and postsurgical or actinic lesions.2–4
The role of pineal gland lesions in causing FRD is 
controversial.5,6
FRD is not listed among the pineal cyst-related symptoms, 
which encompass instead headache, visual disturbances, ver-
tigo, vomiting, and other sleep-related complaints.7 Here we 
report a case of CRSWD associated with a voluminous pineal 
cyst with documented altered melatonin secretion.
REPORT OF CASE
A 14-year-old girl presented with difficulty initiating sleep and 
inability to control her sleep-wake schedule. Since she was 
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11 years old she had complained about a progressive delay in 
sleep onset, difficulty waking up in the morning, remarkable 
sleep inertia, and need for long-lasting naps in the afternoon. 
She also had headache, photophobia, and phonophobia. Clini-
cal and neurological examinations were unremarkable. The 
patient subjectively reported a poor sleep quality (Pittsburgh 
Sleep Quality Index [PSQI] = 12/21), and Morningness-Eve-
ningness questionnaire for children and adolescents disclosed 
an evening chronotype. Brain magnetic resonance imaging 
showed a wide pineal cyst (maximum diameter 20 mm) with-
out evidence of aqueductal or mesencephalic compression (see 
Figure S1 in the supplemental material). The patient underwent 
22 days of actigraphic monitoring (Micro Motionlogger Watch 
actigraph initialized to store data in 1-minute epochs) that 
showed a 24-hour profile characterized by increased sleep on-
set latency (mean = 53.07 minutes, range 13–115 minutes) and 
a free-running sleep-wake rhythm with a phase length (tau) of 
26.96 hours (Figure 1A). The patient underwent in-hospital, 
96-hour, continuous video-polysomnography that showed a 
progressive delay in bedtime, from 9:50 pm to 11:22 pm, mean 
sleep duration of 7 hours with sleep efficiency of 92.67%, REM 
sleep latency of 79 minutes, periodic limb movement index of 
0.6, and occasional diurnal naps.
We performed a 24-hour serum melatonin assay in a room 
with controlled luminance levels and concomitant video-poly-
somnographic and body-core temperature (BcT) monitoring. 
During the daytime room lighting was maintained between 
100–120 lux, from 11:00 pm to 8:00 am lights were off and 
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samples were collected every 2 hours from morning awak-
ening (at 8:30 am). Melatonin levels were measured by ra-
dioimmunoassay (RIA-3972; DRG International, Diagnostic 
GmbH, New Jersey, United States). BcT rhythm was within 
the normal range (Figure 2, lower panel) whereas the mela-
tonin curve showed dim light melatonin onset at 10:30 pm, 
a blunted nocturnal peak (82 ng/L; median maximum peak 
reference values = 100 ng/L, range 81–143 ng/L), a total quan-
tity of melatonin within the lower normal range (area under 
the curve 798 ng*h/L; median area under the curve reference 
values = 1249 ng*h/L, range 657–1321), and higher melato-
nin levels in the morning of the second day (37 ng/L versus 
21 ng/L) (Figure 2, upper panel).9 Based on actigraphic find-
ings, FRD was diagnosed and a treatment with melatonin up 
Figure 1—Prolonged home actigraphy monitoring.
(A) From the sixth day administration of 7 mg of melatonin was discontinued and the major sleep (ie, inactivity) period progressively shifted forward. (B) 
Treatment with 7 mg of melatonin determined a partial alignment of the major sleep period, with persistent sleep onset insomnia and tendency to sleep in 
the early morning. (C) Restoration of wake-sleep rhythm coupled with the day/night cycle after treatment with 14 mg of melatonin.
Figure 2—Melatonin curve plotting (upper panel) together with hypnogram and body-core temperature curve (lower panel).
Maximum peak = 82 ng/L; mean concentration during nighttime period = 68.5 ng/L, area under the curve 798 ng*h/L. Note the dim light melatonin onset 
occurs 1 hour before sleep onset, and melatonin peak is anticipated and lower than normal range. The parallel visualization of sleep, body-core temperature 
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to 7 mg/d was started (administration time at 9:30 pm). Af-
ter 6 months, the patient reported amelioration of sleep qual-
ity (PSQI = 7/21), with partial normalization of sleep-wake 
rhythm (Figure 1B) and occasional diurnal naps (2/wk). Brain 
MRI (performed after 19 months) showed that the cyst vol-
ume was stable. Morning light therapy and administration of 
modafinil up to 300 mg did not achieve any improvement in 
symptoms and therefore were discontinued, whereas melato-
nin was titrated up to 14 mg/d. After 6 months, the patient 
showed further improvement in sleep quality (PSQI = 4/12), 
the need for daytime sleep had disappeared, and she was able 
to restore her social functions. Actigraphy showed a complete 
realignment of the sleep-wake rhythm (tau = 23.93 hours; 
Figure 1C).
DISCUSSION
The current study reports the restoration of a normal sleep-
wake cycle after high-dose melatonin administration in a girl 
with a voluminous pineal cyst. Although data about the indica-
tion and effectiveness of melatonin treatment in free-running 
sighted subjects arise from few case reports without sufficient 
level of evidence,10 based on the altered melatonin curve profile 
we decided to use it to treat our patient. Melatonin titration 
up to high doses (14 mg/d) was empirically guided based on 
clinical and actigraphic follow-up evaluation. The restoration 
of a normal sleep-wake cycle after exogenous administration 
of melatonin point to a possible role of altered melatonin secre-
tion in the FRD observed in our patient.11
Indeed, in our patient the melatonin curve profile showed 
subtle alterations (advanced dim light melatonin onset, blunted 
nocturnal peak, higher levels at morning) consistent with 
an altered secretion, whereas BcT rhythm did not show any 
alteration.
We could speculate that the altered melatonin secretion 
could be related to the parenchymal changes of the pineal gland 
due to the cyst. Nonetheless, given the non-compressive nature 
of the cyst, the role of the pineal cyst in alteration of melatonin 
secretion is uncertain; however, a correlation between solid pi-
neal parenchyma and maximum melatonin concentration over 
24 hours (higher slope of melatonin secretion in solid gland 
compared to cystic gland) has been previously reported.11
Desynchronization between melatonin and BcT rhythms 
could instead be due to the fact that BcT rhythm is mainly 
driven by the homeostatic process and secondarily by the cir-
cadian system and therefore, it may be inferred that altered 
melatonin secretion is strong enough to impair the sleep-wake 
rhythm, but not enough strong to influence BcT profile.12
However, the issue remains controversial, as 24-hour mel-
atonin levels vary widely among healthy subjects, making 
the distinction between normal and altered values difficult 
and a recent study did not find any alteration of the sleep pa-
rameters after pineal gland resection other than a depletion 
of salivary melatonin below the threshold of 3 pg/mL.6 The 
current case highlights that patients presenting with a vo-
luminous pineal cysts should be referred to sleep clinicians 
in order to recognize, and eventually characterize (through 
assessments of temperature, melatonin and sleep-wake 
rhythm), a possible CRSWD.
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